Spago Nanomedical AB (publ)

DB:7UX Stock Report

Market Cap: €5.5m

Spago Nanomedical Management

Management criteria checks 2/4

Spago Nanomedical's CEO is Mats Hansen, appointed in Jan 2015, has a tenure of 9.17 years. total yearly compensation is SEK2.08M, comprised of 78.7% salary and 21.3% bonuses, including company stock and options. directly owns 0.071% of the company’s shares, worth €3.92K. The average tenure of the management team and the board of directors is 5.2 years and 0.8 years respectively.

Key information

Mats Hansen

Chief executive officer

kr2.1m

Total compensation

CEO salary percentage78.7%
CEO tenure9.2yrs
CEO ownership0.07%
Management average tenure5.2yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mats Hansen's remuneration changed compared to Spago Nanomedical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-kr42m

Sep 30 2023n/an/a

-kr41m

Jun 30 2023n/an/a

-kr42m

Mar 31 2023n/an/a

-kr44m

Dec 31 2022kr2mkr2m

-kr39m

Sep 30 2022n/an/a

-kr39m

Jun 30 2022n/an/a

-kr41m

Mar 31 2022n/an/a

-kr43m

Dec 31 2021kr2mkr1m

-kr39m

Sep 30 2021n/an/a

-kr32m

Jun 30 2021n/an/a

-kr27m

Mar 31 2021n/an/a

-kr20m

Dec 31 2020kr2mkr1m

-kr19m

Sep 30 2020n/an/a

-kr20m

Jun 30 2020n/an/a

-kr21m

Mar 31 2020n/an/a

-kr21m

Dec 31 2019kr2mkr1m

-kr20m

Sep 30 2019n/an/a

-kr18m

Jun 30 2019n/an/a

-kr15m

Mar 31 2019n/an/a

-kr13m

Dec 31 2018kr1mkr1m

-kr11m

Compensation vs Market: Mats's total compensation ($USD196.43K) is below average for companies of similar size in the German market ($USD390.92K).

Compensation vs Earnings: Mats's compensation has increased whilst the company is unprofitable.


CEO

Mats Hansen (52 yo)

9.2yrs

Tenure

kr2,081,000

Compensation

Dr. Mats Hansen, MSc., PhD, serves as the Chief Executive Officer of Spago Nanomedical AB (publ) since 2015. Dr. Hansen has experience from different companies in the life science industry. He served at A...


Leadership Team

NamePositionTenureCompensationOwnership
Mats Hansen
Chief Executive Officer9.2yrskr2.08m0.071%
SEK 3.9k
Hanna Olsson
Chief Financial Officer5.2yrsno data0.013%
SEK 686.5
Oskar Axelsson
Head of Research & Chief Scientific Officerno datano data0.031%
SEK 1.7k
Paul Hargreaves
Chief Development Officer2.5yrsno data0.011%
SEK 610.3

5.2yrs

Average Tenure

53yo

Average Age

Experienced Management: 7UX's management team is seasoned and experienced (5.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Hans Arwidsson
Independent Chairman of the Boardless than a yearno datano data
Sten Nilsson
Medical Advisorless than a yearkr95.00k0.0081%
SEK 446.9
Alan Raffensperger
Independent Directorless than a yearno datano data
Peter Leander
Medical Advisorless than a yearkr95.00kno data
Kari Gronas
Independent Director6.2yrskr95.00k0.037%
SEK 2.0k
Per Hall
Medical Advisor1.8yrsno datano data
Nicklas Westerholm
Independent Director4.6yrskr95.00k0.0037%
SEK 201.8
Timothy Roberts
Medical Advisor1.8yrsno datano data
Kristian Pietras
Medical Advisorless than a yearno datano data
Austin Smith
Medical Advisorless than a yearno datano data

0.8yrs

Average Tenure

64yo

Average Age

Experienced Board: 7UX's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.